Therapeutic Products Act (HMG)
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Swedish law
|
| gptkbp:abbreviation |
gptkb:HMG
|
| gptkbp:appliesTo |
pharmacovigilance
advertising of therapeutic products authorisation of therapeutic products distribution of therapeutic products manufacture of therapeutic products market surveillance of therapeutic products |
| gptkbp:country |
gptkb:Switzerland
|
| gptkbp:countryOfPublication |
gptkb:French
gptkb:German gptkb:Italian |
| gptkbp:dateEnacted |
2000-12-15
|
| gptkbp:enactedBy |
gptkb:Swiss_Federal_Assembly
|
| gptkbp:enteredIntoForce |
2002-01-01
|
| https://www.w3.org/2000/01/rdf-schema#label |
Therapeutic Products Act (HMG)
|
| gptkbp:legalCitation |
SR 812.21
|
| gptkbp:officialName |
Heilmittelgesetz
|
| gptkbp:oversees |
gptkb:Swissmedic
|
| gptkbp:purpose |
ensure quality, safety, and efficacy of therapeutic products
|
| gptkbp:regulates |
medical devices
medicinal products therapeutic products |
| gptkbp:relatedTo |
Swiss Narcotics Act
Swissmedic Act |
| gptkbp:website |
https://www.fedlex.admin.ch/eli/cc/2001/422/en
|
| gptkbp:bfsParent |
gptkb:Swissmedic
|
| gptkbp:bfsLayer |
7
|